Evidence map›Paper›PMID 30366473›Full record

ArticleMolecules (Basel, Switzerland)2018

Studies on the Chemical Diversities of Secondary Metabolites Produced by

You-Min Ying, Lu Huang, Ting Tian, Cui-Yu Li, Shi-Lei Wang, Lie-Feng Ma, Wei-Guang Shan, Jian-Wei Wang, Zha-Jun Zhan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

You-Min YingCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. ymying@zjut.edu.cn.
Lu HuangCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. 15958025120@163.com.
Ting TianCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. m17816037931@163.com.
Cui-Yu LiCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. aalicuiyu@163.com.
Shi-Lei WangCollege of Biology and Environment Engineering, Zhejiang Shuren University, Hangzhou 310015, China. wangshilei1105@163.com.
Lie-Feng MaCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. maliefeng@zjut.edu.cn.
Wei-Guang ShanCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. tianranyaowu@zjut.edu.cn.
Jian-Wei WangCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. wangjianwei@zjut.edu.cn.
Zha-Jun ZhanCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. zjnpr@zjut.edu.cn.

Funding

Natural Science Foundation of Zhejiang Province LY17B020011Science and Technology Plan Project of Zhejiang Province 2016C33075Science and Technology Plan Project of Zhejiang Province LGF18B020001
6 · The paper itself

Abstract

The One Strain Many Compounds (OSMAC) method was applied to explore the chemical diversities of secondary metabolites produced by

Indexed as

Cell Line, TumorCell SurvivalHumansIndole AlkaloidsMagnetic Resonance SpectroscopyNeosartoryaPaclitaxelPyridinesSesquiterpenesIndole AlkaloidsPaclitaxelPyridinespyripyropene ASesquiterpenesNeosartorya fischeriOSMACpyripyropenessecondary metabolites

Identifiers

PMID30366473
PMCPMC6278566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.